Welcome to Westonci.ca, where your questions are met with accurate answers from a community of experts and enthusiasts. Get detailed answers to your questions from a community of experts dedicated to providing accurate information. Discover detailed answers to your questions from a wide network of experts on our comprehensive Q&A platform.
Sagot :
Clinical practitioners in the United States continue to underutilize inhaled corticosteroids in the management of mild-to-moderate adult asthma.
In a cohort of patients aged 18 and older with FEV(1) values between 60% and 100% of predicted normal, the aim of this experiment was to determine the clinical effects, health-related quality of life, cost, and cost-effectiveness of inhaled corticosteroid therapy.
We compared the use of inhaled corticosteroid therapy along with quick relievers (such as short-acting beta-agonists) on an as-needed basis to the use of quick relievers alone.
To predict symptoms, acute exacerbations, quality-adjusted life years (QALYs), health care expenses, and cost-effectiveness, evaluated in both dollars per QALY gained and dollars per symptom-free day gained, a mathematical simulation model was created.
Learn more about corticosteroids:
https://brainly.com/question/28255810
#SPJ4
The complete question is '' what is the cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model''.
We hope you found this helpful. Feel free to come back anytime for more accurate answers and updated information. Thank you for your visit. We're committed to providing you with the best information available. Return anytime for more. Get the answers you need at Westonci.ca. Stay informed by returning for our latest expert advice.